US FDA May Start To Miss User Fee Deadlines

 
• By Nielsen Hobbs

As the COVID-19 response begins to strain agency’s resources, Commissioner Hahn acknowledges that ‘it is possible that we will not be able to sustain our current level of performance indefinitely’ in other review areas.

Overheated Car Engine_745998352_1200.jpg
The US FDA's product review engine is still running despite the strain of COVID-19, but it's starting to overheat.

More from Product Reviews

More from Pink Sheet